AquAdvantage Salmon
FDA has approved a new animal drug application concerning AquAdvantage Salmon, a genetically engineered Atlantic salmon. Documents related to this approval are available below.
News
Approval Documents
AquAdvantage Salmon Approval Letter and Appendix AquAdvantage Salmon FOI Summary (PDF - 3.7MB)AquAdvantage Salmon Environmental Assessment (PDF - 9.6MB)AquAdvantage Salmon FONSI (PDF - 252KB)AquAdvantage Salmon - Response to Public Comments on the Environmental Assessment AquAdvantage Salmon - FDA Response to Public Comments to the Veterinary Medicine Advisory Committee AquAdvantage Salmon - FDA Analysis of Potential Impacts on the Environments of the Global Commons and of Foreign Nations not Participating in the Action for NADA # 141-454 Earth Justice Petition Regarding Pending Application of AquaBounty Technologies for Approval of Genetically-Engineered Salmon - Food and Water Watch Petition that the FDA deem AquaBounty Technologies' genetically engineered AquAdvantage Salmon an unsafe food additive
Environmental Documents
FDA Extends Comment Period on AquAdvantage Salmon Documents [ARCHIVED]- Notice of Draft Environmental Assessment and Preliminary Finding of No Significant Impact Concerning a Genetically Engineered Atlantic Salmon
AquAdvantage Salmon Draft Environmental Assessment (PDF - 3.8MB) [ARCHIVED]AquAdvantage Salmon Preliminary Finding of No Significant Impact (PDF - 62KB) [ARCHIVED]
Public Hearing on the Labeling of Food Made from AquAdvantage Salmon - September 21, 2010
Veterinary Medicine Advisory Committee - September 19-20, 2010
September 19-20, 2010: Veterinary Medicine Advisory Committee Meeting Announcement [ARCHIVED]- Federal Register Notice of Sept 19-20, 2010 Veterinary Medicine Advisory Committee Meeting
An overview of Atlantic salmon, its natural history, aquaculture, and genetic engineering [ARCHIVED]Background Document: The VMAC Meeting on Science-Based Issues Associated with AquAdvantage Salmon [ARCHIVED]Agenda for the AquAdvantage Salmon Veterinary Medicine Advisory Committee Meeting [ARCHIVED]Meeting Participants for Aquadvantage Salmon Veterinary Medicine Advisory Committee [ARCHIVED]Charge to the VMAC for the AquAdvantage Salmon Meeting [ARCHIVED]Briefing Packet for AquAdvantage Salmon Veterinary Medicine Advisory Committee (PDF - 2.8MB) [ARCHIVED]Environmental Assessment for AquAdvantage Salmon (Aqua Bounty Technologies, Inc.) (PDF - 1.1MB) [ARCHIVED]Questions and Answers [ARCHIVED]Key Facts Commonly Misunderstood [ARCHIVED]Presentations from the September 20, 2010 Veterinary Medicine Advisory Committee Meeting [ARCHIVED]Chairman's Report for the September 20, 2010 Veterinary Medicine Advisory Committee Meeting (PDF - 134KB) [ARCHIVED]Transcript for the September 19, 2010 Veterinary Medicine Advisory Committee Meeting (PDF - 316KB) [ARCHIVED]Transcript for the September 20, 2010 Veterinary Medicine Advisory Committee Meeting (PDF - 723KB) [ARCHIVED]